xigduo
astrazeneca ab - hydrochlorid metformín, dapagliflozin propanediol monohydrát - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - xigduo je indikovaný u dospelých na liečbu diabetes mellitus 2. typu ako doplnok stravy a cvičenia:• u pacientov s nedostatočne kontrolovanou na ich maximálne tolerované dávkou metformínom sám • v kombinácii s inými liekmi na liečbu cukrovky u pacientov s nedostatočne kontrolovanou s metformínom a tieto lieky• u pacientov, ktorí sa už liečia s kombináciou dapagliflozin a metformínom ako samostatné tablety. pre študijné výsledky s ohľadom na kombináciu terapií, vplyv na glykemický kontroly a kardiovaskulárne udalosti, a populácií študoval, pozri časť 4. 4, 4. 5 a 5.
sitagliptin/metformin sandoz 50 mg/1000 mg filmom obalené tablety
sandoz gmbh, rakúsko - metformín a sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
sitagliptin/metformin sandoz 50 mg/850 mg filmom obalené tablety
sandoz gmbh, rakúsko - metformín a sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
sitagliptin/metformin grindeks 50 mg/1000 mg filmom obalené tablety
as grindeks, lotyšsko - metformín a sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
sitagliptin/metformin grindeks 50 mg/850 mg filmom obalené tablety
as grindeks, lotyšsko - metformín a sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
sitagliptin/metformin teva 50 mg/850 mg
teva pharmaceuticals slovakia s.r.o., slovensko - metformín a sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
sitagliptin/metformin teva 50 mg/1000 mg
teva pharmaceuticals slovakia s.r.o., slovensko - metformín a sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
eucreas
novartis europharm limited - vildagliptin, hydrochlorid metformín - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
zomarist
novartis europharm limited - vildagliptin, hydrochlorid metformín - diabetes mellitus, typ 2 - lieky používané pri cukrovke - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.
metformin mylan xr 750 mg
mylan ireland limited, Írsko - metformín - 18 - antidiabetica (vrÁtane inzulÍnu)